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Abstract  The important functions of the endothelium and the relationship between cardiovascular risk factors and 
endothelial dysfunction suggest the primary role of this tissue as a target for dietary strategies aimed at the 
prevention from related diseases. Cereals are key component of a healthy and balanced diet, and the presence of  
non-specific lipid-transfer protein 2 (nsLTP2) in wheat represents an added value to contribute to maintain the 
functionality of the vascular endothelium and consequently of the cardiovascular system. Indeed, nsLTP2 
downregulates the expression of the main cell adhesion molecules induced by a pro-inflammatory cytokine and, 
meanwhile, upregulates heme oxigenase-1, exerting a cytoprotective/anti-inflammatory activity. Therefore, nsLTP2 
might represent a food-derived tool to protect the vascular system against several pathological conditions. 
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1. Introduction 
It has been ascertained that several well-known 
cardiovascular risk factors, such as arterial hypertension, 
hypercholesterolaemia, diabetes mellitus and smoking  
can affect the endothelium generating the activation  
of endothelial cells. This leads to a deregulation of 
endothelium homeostatic functions, causing a shift toward 
reduced endothelium-dependent vasodilation, increased 
inflammation and a pro-thrombotic state (phenotype) that 
eventually results in overt cardiovascular diseases. In fact, 
endothelial dysfunction has been observed in the early 
stage of most cardiovascular diseases [1] and is associated 
with various pathologies including hypertension, diabetes, 
atherosclerosis pulmonary hypertension, ischaemic heart 
diseases and chronic kidney disease [2]. The severity  
of endothelial dysfunction has been shown to have a 
prognostic value for cardiovascular pathologic events and 
its early clinical detection may become a critical point in 
cardiovascular disease prevention. In the cardiovascular 
continuum, endothelial activation/dysfunction represent 
reversible conditions, which can be targeted by nutritional 
strategies aimed at cardiovascular diseases contention. 
Although being a complex and multifactorial phenomenon,  
endothelial dysfunction is tightly associated with an 
increased production of reactive oxygen species (ROS) [3] 
leading to oxidative stress which is responsible for an 
increased vascular endothelial permeability and coupled 
with alterations in endothelial signal transduction and 
redox-regulated transcription factors [4,5]. 
The susceptibility of vascular cells to oxidative stress is 
a function of the overall balance between the degree of 
oxidative stress and cell antioxidant defence capability [6]. 
Once defined as an imbalance between pro-and anti-
oxidants, oxidative stress is now regarded as an impaired 
redox signalling and equilibrium, ultimately leading to cellular 
damage [2]. Another common underlying mechanism of 
endothelial dysfunction is represented by inflammation, 
which is closely interrelated with oxidative stress [7]. 
Inflammation might turn from a physiological defence 
response to a chronic condition, in which a disruption of 
the normal function of endothelial cells takes place. 
Accordingly, there is a persistent low-grade inflammatory 
phenotype of the vasculature observed in most cardiovascular 
diseases [8]. Various inflammatory cytokines are involved 
in this process and, among them, Tumor necrosis  
factor-alpha (TNF-α) is one of the major molecular 
mediators of chronic inflammation [9]. For example, 
circulating levels of TNFα are elevated in patients 
suffering severe heart failure [10] and these levels have a  
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directly proportional correlation with the patient's New 
York Heart Association (NYHA) functional class. Previous 
reports showed the pro-inflammatory activities of TNF-α 
in human endothelial cells [11]. These activities included 
the modulation of the expression of adhesion molecules 
such as Vascular Cell Adhesion Molecule 1 (VCAM-1) 
and Intercellular Adhesion Molecule 1 (ICAM-1). 
Prolonged use of commercially available pharmacological 
therapies against chronic inflammatory diseases is often 
associated with various side effects. Given the concerns 
about the side effects, there has been also a substantial 
increase in public and scientific awareness about natural 
compounds and their derivatives as safer alternatives or 
coadjutant for the treatment and management of chronic 
diseases. A substantial amount of scientific evidence has 
suggested that food-derived compounds can modulate 
chronic inflammatory conditions affecting the balance 
between pro/anti-inflammatory cytokines [12,13]. Dietary 
proteins, a source of essential amino acids, necessary for 
growth and maintenance of physiological functions, may 
also represent a source of biologically active peptides. 
These molecules, usually smaller that 10kDa [14], may 
exist naturally in food or be encoded within protein 
primary sequence, from which they can be released mainly 
through proteolysis (during gastrointestinal digestion  
in vivo, bacterial fermentation and ripening in food 
processing or in vitro enzymatic hydrolysis) in order to be 
bioactive [15,16]. Depending on the aminoacidic composition 
of the polypeptide chain these peptides can exhibit a wide 
range of biological activities (antimicrobial properties, 
blood pressure-lowering capacity, ACE – inhibitory effects, 
cholesterol-lowering ability, antithrombotic and antioxidant 
activities, mineral binding and opioid-like activities), 
which can be relevant in health promotion against various 
chronic and degenerative disorders such as CVD [17].  
In the last decade, the presence of the bioactive peptide 
lunasin has been reported in cereals [18], but we demonstrated 
the absence of lunasin in soft and durum wheat kernels  
by chemical and molecular analyses [19]. On the other 
hand, the analysis of different wheat extracts purified  
by chromatographic techniques allowed the identification 
of non-specific lipid-transfer protein (nsLTP) type 2  
from Triticum turgidum subsp. turanicum [20] with  
gastro and intestinal resistance. Moreover, in human 
umbilical vein endothelial cells (HUVEC) nsLTP2 has been 
demonstrated to exert antioxidant activity and potential 
cytoprotective effects following oxidative or inflammatory 
stimulations [20]. 
In this paper, using a cell model of endothelial 
dysfunction (HUVECs challenged with TNF-α), we 
investigated the potential ability of wheat derived nsLTP2 
to modulate not only vascular adhesion molecules, but 
also Heme oxygenase (HO)-1, the inducible isoform of the 
first and rate-limiting enzyme of heme degradation, that 
has been recognized to have major immunomodulatory 
and anti-inflammatory properties [21]. We demonstrated 
that wheat-derived nsLTP2 may contribute to vascular 
endothelium health protection by modulating specific 
markers of inflammatory processes, such as adhesion 
molecules and cellular regulators of inflammation as  
HO-1, thus representing a potential tool to protect the 
vascular system against various stressors. 
2. Materials and Methods 
2.1. Materials 
Medium M200 phenol red free, LGS supplement kit  
#S-003-K and HUVECs (Human umbilical endothelial 
vein cells) were purchased from GIBCO (Thermo-Fischer 
Scientific, Waltham, MA USA). Recombinant Human 
TNF-α was purchased from PeproTech (PeproTech House, 
London UK). Fetal bovine serum (FBS), bovine serum 
albumin (BSA), Glycine for electrophoresis, Trizma® 
base, gelatin from bovine skin, Dimethyl sulfoxide 
(DMSO), Phosphate buffered saline (PBS), mammalian 
protease inhibitor mixture #P8340, Sodium Fluoride 
(NaF), Phenylmethanesulfonyl fluoride (PMSF), Sodium 
pyrophosphate dibasic, Sodium orthovanadate, sodium 
pyruvate, Zinc protoporphyrin IX (ZnPPIX) and Tin 
Protoporphyrin IX (SnPPIX) and Anti-β actin antibody 
(mouse) were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Nitrocellulose membrane was from GE-
Healthcare. Mini protean® TGX Gels, Clarity™ Western 
ECL Blotting Substrate, DC protein assay kit and 
Precision Plus Protein™ All Blue Prestained Protein 
Standards were purchased from BIORAD (Hercules, CA, 
USA). Anti HO-1 antibody (rabbit), Anti VCAM-1 
antibody (rabbit), HRP-linked Antibody Anti-mouse IgG, 
HRP-linked Antibody Anti-rabbit were from Cell 
Signalling (Cell Signaling Technology, Leiden The 
Netherlands). Anti-ICAM-1 antibody (rabbit) was 
obtained from Abcam (Cambridge, MA USA). Purified 
peptide nsLTP2 was provided by Institute of Food 
Research – Norwich – UK within the European FP7 
programme Bacchus and has been fully characterized as 
reported in [19]. 
2.2. Methods 
2.2.1. Cells Culture and Treatments 
Human Umbilical vein endothelial cells (HUVECs) were 
grown in standard conditions (humidified atmosphere  
at 37°C and 5% CO2) in Phenol red free M200 medium 
(Thermo-Fischer Scientific) supplemented with 10% 
decomplemented fetal bovine serum (FBS) (Sigma-
Aldrich), L-glutamine, growth factors (LSSG Kit - 
Thermo-Fischer Scientific) which was changed every 48h, 
as previously reported [22]. 
Cells were cultured until they reached 80% confluence 
and successively seeded into gelatine-coated multiwell 
plates for treatments. Experiments were conducted with 
cells between passages 3-7. HUVECs were treated or not 
with nsLTP2 at final concentration of 0.01 µM for 24h. 
Afterwards, inflammatory stress was induced using the 
inflammatory cytokine TNF-α (20 ng/mL). The 10nM 
concentration of nsLTP2 was chosen because it has been 
previously demonstrated to exert antioxidant and 
cytoprotective effects in HUVECs following oxidative and 
inflammatory stimulation [20]. 
2.2.2. PAGE and Immunoblotting 
HUVECs (2x105), seeded in 6-well plates were  
pre-treated for 24 h with 0.01μM nsLTP2 and further 24h  
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in the presence or absence of 20 ng/mL TNF- α. At the 
end of the treatment cells were washed twice with ice-cold 
PBS and lysed in Radioimmunoprecipitation assay (RIPA) 
buffer supplemented with protease inhibitors mixture 
(Sigma) and phosphatase inhibitors. Cells were detached 
from the plastic support using cell-scraper, left on  
ice to solubilize for 15 min with periodic vortexing and 
subsequently centrifuged at 12000 rpm for 15 min to 
separate the supernatants. Protein content was determined 
by DC protein assay kit, (Bio-Rad), using Bovine  
Serum Albumin (BSA) solubilized in RIPA buffer as a 
standard.  
Samples (10 μg/lane) were loaded on a 10% SDS-PAGE 
Mini-Protean® TGX™ (Bio-Rad Laboratories) and 
electrophoresed at 200 V for 30-40 min. Samples were 
loaded alongside 5 μL of Precision Plus Protein™ All 
Blue Prestained Protein Standards (Bio-Rad) to enable 
identification of proteins of interest. The separated 
proteins were then blotted on a nitrocellulose membrane 
(Hybond-C; GE Healthcare, Buckinghamshire, UK) by 
applying to the electrophoretic cell, an electric field of  
110 V for 90 min. Non-specific binding to membrane was 
blocked with Tris-buffered saline/Tween (TTBS), 
containing 5% non-fat dried milk or BSA for 1 hour at 
room temperature. Blots were probed with primary 
antibodies overnight at 4 °C with gentle shaking, washed 
with TTBS (3 x 5 min) and then incubated for 1 h at room 
temperature with secondary horseradish peroxidase (HRP) 
conjugates antibodies. 
Protein bands were detected by chemiluminescence, 
using Clarity™ Western ECL Blotting Substrate (Bio-Rad) 
according to manufacturer’s protocol. Densitometric 
analysis of specific immunolabeled bands was performed 
using the Chemidoc MP (Bio-Rad, Hercules, CA) software. 
Band intensity was normalized to the intensity of the 
corresponding β-actin band and results were expressed as 
fold increase relative to control cells or TNF- α treated 
cells. 
2.2.3. Fluorescence Immunostaining 
HUVECs were seeded on glass cover-slips and  
treated with 10 nM nsLTP2 for 24 h. At the end of the 
treatment, cells were washed with PBS, fixed with 3% 
paraformaldehyde for 15 min, washed with 0.1 M glycine 
in PBS and permeabilized in 70% ice cold ethanol. After 
fixing, the cells were incubated overnight at 4 °C with anti 
HO-1 primary antibody. Subsequently the samples were 
washed with 1% BSA in PBS and incubated with DyLight 
488 labeled secondary antibody (KPL, Gaithersburg, MD) 
for 1 h at room temperature. Nuclei were labelled with 
DAPI (0.01 μg/mL final concentration) for 10 min at room 
temperature. Preparations were mounted on microscope 
slides with Vectashild (Vector Laboratories, Burlingame, 
CA) and images were acquired with Axio Scope.A1 
microscope (Zeiss) at 100x magnification. 
2.2.4. Statistical Analysis 
Data represent mean values with ± respective standard 
deviation (SD) corresponding to three or more independent 
experiments. Differences between means were analysed 
by unpaired Student's t-test with P<0.05 considered to be 
significant. 
3. Results 
3.1. Wheat nsLTP2 Exerts Anti-inflammatory 
Effect Modulating Adhesion Molecules 
Expression 
The endothelial expression of cell-surface adhesion 
molecules, such as VCAM-1, ICAM-1 represents a 
marker of endothelial activation, which is typically 
induced by pro-inflammatory cytokines.  
In order to assess nsLTP2 potential anti-inflammatory 
activity, experiments were conducted in HUVECs  
pre-treated with 10 nM nsLTP2 for 24 h before the 
inflammatory stimulation by TNF-α. Immunoblotting 
analysis showed that 24 h treatment with 20 ng/mL  
TNF-α caused a significant increase in the expression of  
VCAM-1 and ICAM-1 which is significantly decreased 
after a 24 h pre-treatment with 10 nM nsLTP2 (Figure 1).  
 
Figure 1. Effect of nsLTP2 on cell adhesion molecule expression  
in HUVECs treated with TNF-α. After 10 nM nsLTP2 (LTP2)  
pre-treatment for 24 h, HUVECs were stressed with 20 ng/mL TNF-α. 
Cell lysates were subjected to SDS-PAGE and Western blotting analysis, 
using primary antibodies directed to VCAM-1, ICAM-1. Images show a 
representative experiment of three independent analyses. Densitometric 
analysis of bands intensity, normalized to actin, was expressed as % of 
stressed cells and was carried out with the ChemiDoc MP System 
(BIORAD). Data represent means ± SD of three independent 
experiments. §p < 0.05, vs control HUVECs; *p < 0.05, vs HUVECs 
stressed with TNF-α 
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3.2. Wheat nsLTP2 Effect on Heme 
Oxygenase (HO-1) in Vascular 
Endothelial Cells 
Since HO-1 is usually involved in inflammatory 
processes, in order to verify if wheat peptide nsLTP2 
affect HO-1 expression, HUVECs were treated with 10 
nM nsLTP2 for 24 h and cell lysates were subjected to 
immunoblotting analysis. HUVECs treatment with 10 nM 
nsLTP2 for 24 h caused a significant increase in  
HO-1 protein expression, with respect to control cells 
(Figure 2). 
 
Figure 2. Effect of nsLTP2 on HO-1 protein expression level in 
HUVECs. After treatment with 10 nM nsLTP2 for 24 h, cells lysates 
were subjected to SDS-PAGE and Western blotting analysis of HO-1 
protein expression levels. The image shows a representative experiment 
of three independent analyses. Densitometric analysis of HO-1 
expression, normalized to actin, is expressed as fold increase over control 
and was carried out with the ChemiDoc MP System (BIORAD). Data 
represent means ± SD of three independent experiments. §p < 0.05, vs 
control HUVECs 
The fluorescent immunostaining analysis, performed in 
the same experimental conditions, revealed that in 
HUVECs treated with 10 nM nsLTP2 for 24 h a strong 
increase in cell fluorescence was detectable (Figure 3), 
supporting the previously reported result. 
 
Figure 3. Immunofluorescence staining of HO-1 in HUVECs after 10 
nM nsLTP2 treatment for 24 h After treatment with 10 nM nsLTP2, 
HUVECs were immunolabeled with anti-HO-1 antibody and relative 
fluorescent FITCH-conjugated secondary antibody then visualized using 
immunofluorescence microscopy (Zeiss Axio Scope.A1, magnification 
100x). Nuclei were stained with DAPI 
3.3. Comparison of the Inducing Capacity of 
nsLTP2 and Statins on HO-1  
in Endothelial Cells 
As statins, beside their HMG-CoA reductase antagonist 
effect, exert cytoprotective/anti-inflammatory activity by 
inducing HO-1 expression, a comparison between nsLTP2 
and Atorvastatin and Simvastatin effect was performed. 
Immunoblotting analysis showed that upon HUVECs 
treatment with both statins and nsLTP2 at the same 
concentration (10 nM) for 24 h, HO-1 expression was 
significantly up regulated (Figure 4). 
 
Figure 4. Effect of nsLTP2 (LTP2), Atorvastatin and Simvastatin on 
HO-1 protein expression level. HUVECs were treated with 10 nM 
nsLTP2 (LTP2), 10 nM - 50 µM Atorvastatin (A) or 10 nM - 50 µM 
Simvastatin (S) for 24 h. Cell lysates were subjected to SDS-PAGE and 
Western blotting analysis of HO-1 protein expression level. 
Densitometric analysis of HO-1 expression, normalized to actin, is 
expressed as fold increase over control and was carried out with the 
ChemiDoc MP System (BIORAD). Data represent means ± SD of three 
independent experiments. §p < 0.05, compared with control HUVECs 
 
Figure 5. Effect of nsLTP2 on VCAM-1 expression in HUVECs treated 
with TNF-α in the presence or absence of HO-1 inhibitors. HUVECs 
were treated with 10 nM nsLTP in the presence or absence of HO-1 
inhibitors (10nM ZnPP IX and SnPP IX) and subsequently treated with 
20ng/mL TNF-α. Cell lysates were subjected to SDS-PAGE and Western 
blotting analysis of VCAM protein expression level. Densitometric 
analysis of VCAM expression normalized to actin is expressed as % of 
stressed cells and was carried out with the ChemiDoc MP System 
(BIORAD). Data represent means ± SD of three independent 
experiments. §p < 0.05, compared with control HUVECs, *p < 0.05, 
compared with HUVECs stressed by TNF-α. 
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In order to clarify if the observed modulatory effect 
exerted by nsLTP2 on adhesion molecules could be 
mediated by the induction of HO-1, HUVECs were  
treated with two HO-1 inhibitors: Zinc protoporphyrin IX 
(ZnPPIX) and Tin Protoporphyrin IX (SnPPIX) for 24h. 
In HUVECs pre-treated with 10 nM nsLTP2 for 24 h a 
decrease in the expression of VCAM-1 induced by TNF-α 
was detectable, while this effect was abrogated when cells 
were treated with both ZnPPIX and SnPPIX, suggesting 
that the induced expression of HO-1 may be involved in 
the modulatory effect of nsLTP2 on adhesion molecules 
(Figure 5). 
4. Discussion 
The main cardiovascular risk factors are associated with 
a condition of oxidative stress and inflammation able to 
induce a "dysfunctional" endothelial state. The key role of 
the endothelium in vascular homeostasis maintenance and 
the observed correlation between endothelial dysfunction 
and cardiovascular diseases onset and development make 
this tissue a primary target for dietary strategies aimed at 
cardiovascular diseases prevention. A direct correlation 
between the intake of whole grains, including wheat and 
derived products and the reduction in risk of developing 
chronic degenerative diseases has been reported [23,24]. 
Initially attributed to the abundance of fibers and 
micronutrients, this beneficial effect is today more centered 
on their bioactive components content, responsible for the 
nutraceutical value of these foods [25]. With the aim of 
searching for peptides, which may characterize different 
wheat varieties for their biological activity and nutraceutical 
properties, we previously identified a 7 kDa peptide  
(non-specific lipid-transfer protein type 2, nsLTP2)  
from a pool of soft and durum wheat varieties and  
from KAMUT® khorasan wheat (Triticum turgidum ssp. 
turanicum) [19]. In a previous study we demonstrated the 
antioxidant/cytoprotective activity of nsLTP2 in the same 
experimental model [20]. Since oxidative stress and 
inflammation represent the basis of endothelial dysfunction, 
these activities could be considered as potentially beneficial 
for vascular health maintenance. 
The aim of the present work is was to deepen the analysis 
of the mechanism at the basis of potential anti-inflammatory 
activity of nsLTP2. Experiments were conducted in order 
to verify a possible modulatory effect exerted by nsLTP2 
on adhesion molecule expression, since they are overexpressed 
in inflammatory conditions, representing a biomarker of 
endothelial activation. Immunoblotting analyses suggest 
that nsLTP2 at physiologically achievable concentration 
(10 nM) is able to significantly reduce the increased 
expression of cell adhesion molecules observed following 
HUVECs treatment with TNF-α (20 ng/ml). These results 
are in accordance with other studies in which the potential 
protective effects of phytochemicals was analysed in the 
same experimental model of endothelial inflammation 
[26,27,28,29]. The analysis of the potential anti-inflammatory 
effect of nsLTP2 was extended to the evaluation of its 
effect on HO-1 expression. HO-1, beside its well known 
role in heme catabolism, has been recognized as being part 
of endogenous antioxidant defense system [30]. Numerous 
scientific evidence highlighted the important physiological 
and beneficial role of HO-1 in the vasculature particularly 
on vascular endothelium toward which it exerts pleiotropic, 
including antiapoptotic, anti-inflammatory and antioxidant 
actions [31]. Overexpression of HO-1 in human endothelial 
cells has been shown to protect against tert-butyl 
hydroperoxide cytotoxicity [32], pro-apoptotic cytokines 
[33] and crotonaldhyeide [34]. In addiction, HO-1 decreases 
oxidative stress induced by H2O2 and/or NADPH oxidase 
[35] and may attenuate inflammatory response induced by 
LPS, TNF-α and other inflammatory cytokines. OH-1  
has been demonstrated to decrease the up-regulation of 
cyclo-oxygenase-2 (COX-2), E-selectin, vascular cell 
adhesion molecule-1 (VCAM-1), intercellular adhesion 
molecule-1 (ICAM-1), and monocyte chemoattractant 
protein-1 (MCP-1) secretion [31]. 
Therefore, in order to verify if nsLTP2 modulates HO-1 
expression, HUVECs were treated with 10 nM nsLTP2 for 
24 h and cell lysates were subjected to immunoblotting 
analysis. HUVECs treatment with nsLTP2 caused a 
significant increase in HO-1 protein expression, compared 
to control cells. This data suggest an anti-inflammatory 
activity exerted by the selected peptide due to the 
activation of one of the enzyme linked to endogenous 
antioxidant defence system. These results are confirmed 
by immunofluorescent analysis. 
Some common dietary phytochemicals are known  
HO-1 inducers [36] as well as drugs currently used in 
therapy [31] for example, statins. In particular, simvastatin, 
rosuvastatin and atorvastatin have been shown to increase 
HO-1 promoter activity and increase the antioxidant capacity 
in endothelial cells [37], displaying a vasculoprotective 
and anti-inflammatory activity independent from their 
antagonist effect on HMG-CoA reductase. Therefore, 
nsLTP2 effect on HO-1 expression was compared to  
that of statins. HUVECs were treated with simvastatin, 
atorvastatin or nsLTP2 for 24 h and HO-1 protein 
expression was examined by immunoblotting. HO-1  
up-regulation occurred following cell treatment with both 
nsLTP2 and statins at the same concentration (10nM), this 
up regulation increases at higher statin concentrations (50 
µM), commonly used to evaluate the effect of these drugs 
on biological activities, as reported in literature [38]. Since 
the induction of HO-1 has been linked to the inhibition  
of endothelial adhesion molecules expression and this 
mechanism is considered to be, at least in part, responsible 
for the resulting amelioration of inflammation at  
vascular level [39], we next examined whether the HO-1 
up-regulation, induced by nsLTP2, was correlated to  
the down-regulation of adhesion molecule expression  
(i.e. VCAM) induced by TNF-α. Consequently, experiments 
were conducted using two HO-1 inhibitors: Zinc 
Protoporphyrin IX (ZnPPIX) and Tin Protoporphyrin IX 
(SnPPIX). HUVEC pre-treatment with nsLTP2 resulted in 
a decreased expression of VCAM-1 induced by TNF-α 
and this effect is counteracted by HO-1 inhibitors, suggesting 
that the induced expression of HO-1 may contribute to the 
underlying mechanism of the anti-inflammatory activity 
exerted nsLTP2. Similarly, this mechanism has been 
reported for other natural compounds [40]. 
Taken together, these results suggest that nsLTP2, as a 
HO-1 inducer, might represent a potential tool to protect 
the vascular system against various stressors, preventing 
several pathological conditions.  
 
391 Journal of Food and Nutrition Research  
These results are particularly relevant, as they were 
observed at physiologically achievable concentrations that 
were chosen according to data presented in the literature [41]. 
5. Conclusions 
There are many risk factors able to induce oxidative stress 
and inflammation and create an endothelial dysfunctional 
state. The important functions of the endothelium and the 
relationship between risk factors and endothelial dysfunction 
in the onset of cardiovascular disease makes this tissue a 
primary target for dietary strategies aimed at the prevention 
of the onset of these diseases. Cereals are key component 
of a healthy and balanced diet, as highlighted by their 
location at the base of different national nutritional 
pyramids. Thanks also to the presence of nsLTP2, they may 
contribute to maintain the functionality not only of the 
cardiovascular system and in particular of the vascular 
endothelium. A randomized, double-blind, clinical trial is 
now in progress to evaluate haemodynamic and metabolic 
effects of nsLTP2-rich wheat products assumption in a 
cohort of pre-hypertensive subjects. 
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